Feds Dismiss Charges Against 1 of Quartet Accused of Insider Trading on Abbott Laboratories (ABT)/Advanced Medical Optics, Inc. (EYE) Buyout  
5/7/2013 8:20:43 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Federal regulators drop charges against 1 of the accused charged with insider trading in connection with Abbott's 2009 buyout of Advanced Medical Optics. Federal investigators late last month moved to drop charges against 1 of the quartet of suspects accused of insider trading in connection with Abbott's (NYSE:ABT) $2.8 billion buyout of Advanced Medical Optics in 2009.Defendant Roger Wittenbach was accused alongside former baseball player Doug DeCinces and 2 others of acting on information allegedly obtained from DeCinces, who investigators said learned of the impending buyout from then-CEO James Mazzo. Prosecutors suddenly requested a dismissal of the case against Wittenbach late last month, and U.S. District Judge Andrew Guilford approved the motion in short order, although no reason was given for the dismissal.

Help employers find you! Check out all the jobs and post your resume.